Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.
Saved in:
| Title: | Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. |
|---|---|
| Authors: | Abdelhak A; Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco, San Francisco., Benkert P; Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Multiple Sclerosis Center, Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Schaedelin S; Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Multiple Sclerosis Center, Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Boscardin WJ; Departments of Medicine and Epidemiology & Biostatistics, University of California at San Francisco, San Francisco., Cordano C; Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco, San Francisco.; Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Oechtering J; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Multiple Sclerosis Center, Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Ananth K; Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco, San Francisco., Granziera C; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Multiple Sclerosis Center, Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland., Melie-Garcia L; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Multiple Sclerosis Center, Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland., Montes SC; Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco, San Francisco., Beaudry-Richard A; Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco, San Francisco., Achtnichts L; Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland., Oertel FC; Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco, San Francisco., Lalive PH; Unit of Neuroimmunology, Division of Neurology, Department of Clinical Neurosciences, University Hospital of Geneva and Faculty of Medicine, Geneva, Switzerland., Leppert D; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Multiple Sclerosis Center, Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Müller S; Department of Neurology, Cantonal Hospital St Gallen, St Gallen, Switzerland., Henry RG; Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco, San Francisco., Pot C; Department of Clinical Neurosciences, Service of Neurology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., Matthias A; Department of Clinical Neurosciences, Service of Neurology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., Salmen A; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Oksenberg JR; Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco, San Francisco., Disanto G; Multiple Sclerosis Center, Department of Neurology, Neurocenter of Southern Switzerland, ECO, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Zecca C; Multiple Sclerosis Center, Department of Neurology, Neurocenter of Southern Switzerland, ECO, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., D'Souza M; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Multiple Sclerosis Center, Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Du Pasquier R; Department of Clinical Neurosciences, Service of Neurology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., Bridel C; Unit of Neuroimmunology, Division of Neurology, Department of Clinical Neurosciences, University Hospital of Geneva and Faculty of Medicine, Geneva, Switzerland., Gobbi C; Multiple Sclerosis Center, Department of Neurology, Neurocenter of Southern Switzerland, ECO, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Multiple Sclerosis Center, Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Hauser SL; Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco, San Francisco., Cree BAC; Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco, San Francisco., Kuhle J; Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Multiple Sclerosis Center, Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Green AJ; Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco, San Francisco.; Department of Ophthalmology, University of California at San Francisco, San Francisco. |
| Corporate Authors: | UCSF, MS EPIC, and the SMSC Study Teams |
| Source: | JAMA neurology [JAMA Neurol] 2023 Dec 01; Vol. 80 (12), pp. 1317-1325. |
| Publication Type: | Observational Study; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6157 |
|---|---|
| DOI: | 10.1001/jamaneurol.2023.3997 |
